Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 51

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 51
---
 currently intend to use
the net proceeds from the sale of securities under this prospectus for general corporate purposes, including manufacturing expenses, clinical
trial expenses, research and development expenses and general and administrative expenses. We may also use a portion of the net proceeds
to in-license, invest in or acquire businesses or technologies that we believe are complementary to our own, although we have no current
plans, commitments or agreements with respect to any acquisitions. As of the date of this prospectus, we cannot specify with certainty
all of the particular uses of the proceeds from the sale of securities under this prospectus. Accordingly, we will retain broad discretion
over the use of such proceeds. Pending the use of the net proceeds from the sale of securities under this prospectus as described above,
we intend to invest the net proceeds in investment-grade, interest-bearing instruments.

<div align='center'>14

DESCRIPTION OF CAPITAL STOCK</div>

Our articles of
incorporation authorize us to issue up to 217,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of
preferred stock, par value $0.01 per share. As of August 11, 2025, we had 36,229,842 shares of common stock outstanding and no shares
of preferred stock outstanding.

The following summary description
of our capital stock is based on the provisions of our articles of incorporation and bylaws and the applicable provisions of the Washington
Business Corporation Act (“WBCA”). This information is qualified entirely by reference to the applicable provisions of our
articles of incorporation, bylaws and the WBCA. For information on how to obtain copies of our articles of incorporation and bylaws, which
are exhibits to the registration statement of which this prospectus is a part, see “Where You Can Find More Information” and
“Incorporation of Certain Information by Reference.”

Common Stock

Voting

Our common stock is entitled
to one vote for each share held on all matters submitted to a vote of the shareholders, including the election of directors, except for
matters that are voted on exclusively by a separate class or series of our shareholders and not by the holders of common stock, and does
not have cumulative voting rights. Accordingly, the holders of a majority of the shares of our common stock entitled to vote in any election
of directors can elect all of the directors standing for election.

Dividends

Subject to preferences that
may be applicable to any then